Reproductive System and Hormonal Control (3B) - Bio & Biochem

SECTION 1

Historical Context & Motivation

The elucidation of reproductive endocrinology represents one of the great triumphs of 20th-century physiology, uniting classical anatomy with the emerging science of hormonal signaling. For centuries, the mechanisms underlying puberty, fertility, and sexual development remained mysterious, often attributed to vague "vital spirits." The realization that discrete chemical messengers—steroid and peptide hormones—orchestrate the entire reproductive cascade fundamentally changed medicine and gave rise to modern contraception, assisted reproductive technologies, and treatments for endocrine disorders. Understanding the hypothalamic-pituitary-gonadal (HPG) axis is now indispensable for the MCAT, as it integrates endocrine signaling, feedback control, and organ-system physiology into a single regulatory framework.

1905 • The Hormone Concept

Ernest Starling coins the term hormone (from Greek ὁρμᾶν, "to set in motion") after work on secretin, establishing the principle that bloodborne chemical messengers coordinate distant organ function.

1929 • Isolation of Estrogen

Edward Doisy and Adolf Butenandt independently isolate and characterize estrone, the first purified sex steroid, from the urine of pregnant women—providing molecular proof that steroid hormones regulate reproductive tissues.

1960 • The Oral Contraceptive Pill

FDA approval of Enovid demonstrates that exogenous steroid hormones can exploit negative feedback on the HPG axis to suppress ovulation, ushering in a new era of reproductive medicine.

1971 • GnRH Structure Determined

Andrew Schally and Roger Guillemin characterize the decapeptide gonadotropin-releasing hormone (GnRH), revealing the hypothalamic master switch of the reproductive axis. Both receive the Nobel Prize in 1977.

1978 • First IVF Birth

Louise Brown is born following in vitro fertilization, made possible by pharmacologic manipulation of the HPG axis with gonadotropins—transforming infertility treatment.

These milestones underscore a central question that the MCAT expects you to answer with mechanistic precision: How does the brain integrate environmental and internal signals to regulate gametogenesis, sex steroid production, and reproductive cycling through hierarchical hormonal feedback? The following sections dissect each layer of the HPG axis, the molecular details of the menstrual and spermatogenic cycles, and the clinical consequences of axis disruption.

SECTION 2

Core Principles of Reproductive Hormonal Control

Reproductive endocrinology is governed by a hierarchical set of principles that recur throughout organ-system physiology. The hypothalamus serves as the neuroendocrine integrator, transducing neural inputs into pulsatile secretion of GnRH. The anterior pituitary amplifies this signal by releasing the gonadotropins FSH and LH, which act on the gonads (ovaries or testes) to drive gametogenesis and steroidogenesis. The sex steroids and peptide hormones produced by the gonads feed back to regulate the hypothalamus and pituitary, forming closed-loop circuits of both negative and, in a unique reproductive context, positive feedback.

Pulsatile GnRH Secretion

GnRH is released in pulses from the hypothalamic arcuate nucleus. Pulse frequency determines whether the anterior pituitary preferentially secretes FSH (slow pulses) or LH (rapid pulses). Continuous GnRH paradoxically downregulates its own receptor—the basis for GnRH agonist therapy.

Negative Feedback

Gonadal steroids (estradiol, progesterone, testosterone) and peptide hormones (inhibin) suppress GnRH, FSH, and LH release, maintaining homeostatic setpoints.

Positive Feedback (LH Surge)

A unique feature of the female cycle: sustained high estradiol levels (>200 pg/mL for ~50 hours) switch from negative to positive feedback, triggering the mid-cycle LH surge that induces ovulation.

Steroidogenesis Pathway

All gonadal steroids derive from cholesterol via the pregnenolone pathway. Key enzymes include CYP11A1 (side-chain cleavage), aromatase (converts androgens → estrogens), and 5α-reductase (converts testosterone → DHT).

Two-Cell, Two-Gonadotropin Model

In the ovary, theca cells (stimulated by LH) produce androgens, which are transferred to granulosa cells (stimulated by FSH) for aromatization to estradiol. This cooperative model explains why both gonadotropins are essential for ovarian steroid output.

✦

KEY TAKEAWAY

Think of the HPG axis like a thermostat system with a twist: most of the time, rising sex steroid levels turn the "heater" (GnRH/LH/FSH) down—classic negative feedback, just like a room reaching its set temperature. However, in one unique circumstance during the menstrual cycle, the system behaves as though the thermostat cranks up the heat when the room is already warm (positive feedback), producing the LH surge and triggering ovulation. Recognizing when the axis operates in negative versus positive feedback mode is the single most tested concept in reproductive endocrinology on the MCAT.

SECTION 3

The HPG Axis — Visual Overview

The HPG axis showing the three-tier hierarchy: the hypothalamus releases GnRH to the anterior pituitary, which produces FSH and LH to stimulate the gonads. Red dashed lines represent negative feedback from gonadal steroids and inhibin; the green dashed line shows the unique positive feedback loop (sustained high estradiol → LH surge → ovulation).

The diagram above encapsulates the central organizing principle of reproductive endocrinology. At the top of the axis, hypothalamic neurons in the arcuate nucleus secrete GnRH into the hypophyseal portal system—a specialized capillary network that delivers releasing hormones directly to the anterior pituitary without systemic dilution. This anatomical arrangement explains why GnRH concentrations at the pituitary are orders of magnitude higher than in the general circulation. The anterior pituitary gonadotrophs respond by synthesizing and secreting FSH and LH, both glycoprotein hormones that share a common α-subunit with TSH and hCG but differ in their β-subunits, which confer receptor specificity. At the gonadal level, the two-cell model (theca + granulosa in ovary, Leydig + Sertoli in testis) ensures that the gonadotropin signals are translated into sex steroid production and gametogenesis.

SECTION 4

Hormonal Mechanisms — Menstrual Cycle & Spermatogenesis

The Menstrual Cycle: A Coordinated Four-Phase Process

The menstrual cycle averages 28 days and is divided into ovarian and uterine perspectives that proceed in parallel. The follicular phase (days 1–13) corresponds to the uterine proliferative phase: rising FSH recruits a cohort of antral follicles, one of which becomes the dominant follicle by secreting progressively higher levels of estradiol. This estradiol initially exerts negative feedback on FSH (causing atresia of non-dominant follicles) and on LH. However, when estradiol exceeds approximately 200 pg/mL and is sustained for roughly 50 hours, the feedback switches to positive feedback, triggering the massive mid-cycle LH surge that induces ovulation on approximately day 14.

Following ovulation, the ruptured follicle transforms into the corpus luteum, which secretes both progesterone and estradiol during the luteal phase (days 15–28). Progesterone drives the uterine secretory phase, stabilizing the endometrium for potential implantation. Both progesterone and estradiol now exert strong negative feedback on GnRH/LH/FSH, preventing further follicle recruitment. If fertilization does not occur, the corpus luteum degenerates (luteolysis), hormone levels plummet, and the endometrium sheds—menstruation (day 1 of the next cycle). The withdrawal of inhibition allows FSH to rise again, recruiting a new follicular cohort.

Spermatogenesis & Male Hormonal Axis

In males, the HPG axis operates without cycling; instead, it maintains a relatively steady-state output. Leydig cells in the interstitium respond to LH by producing testosterone, which diffuses into Sertoli cells within the seminiferous tubules. Sertoli cells, stimulated by FSH, support all stages of spermatogenesis—from spermatogonia through primary and secondary spermatocytes to spermatids and ultimately mature spermatozoa. The entire process takes approximately 64 days in humans. Sertoli cells also produce androgen-binding protein (ABP) to concentrate testosterone locally and inhibin B to selectively suppress FSH via negative feedback. Testosterone itself feeds back on both the hypothalamus and anterior pituitary to inhibit GnRH and LH secretion.

⚠

MCAT High-Yield Point

Inhibin selectively suppresses FSH (not LH) at the pituitary. This is frequently tested. In males, inhibin B from Sertoli cells performs this role; in females, inhibin A (from the corpus luteum during the luteal phase) and inhibin B (from granulosa cells during the follicular phase) are relevant. Activin opposes inhibin by stimulating FSH release.

SECTION 5

Detailed Breakdown of Hormonal Fluctuations

Relative plasma concentrations of estradiol, progesterone, LH, and FSH across a 28-day menstrual cycle. Note the sharp LH surge at mid-cycle (day 14, green dashed line) triggered by sustained high estradiol (positive feedback). Progesterone dominates the luteal phase and is responsible for the secretory transformation of the endometrium.

Phase	Days	Dominant Hormones	Key Events
Menstrual	1–5	Low E₂, low progesterone; FSH begins to rise	Endometrial shedding; loss of hormonal support triggers ischemia and sloughing of the functional layer
Follicular / Proliferative	1–13	Rising FSH → rising E₂ from dominant follicle; inhibin B rises	Follicle recruitment, selection, and dominance; endometrial proliferation driven by estradiol; cervical mucus thins
Ovulation	~14	LH surge (positive feedback from high E₂); FSH co-surge	Resumption of oocyte meiosis I → arrest at metaphase II; follicular rupture; oocyte enters fallopian tube
Luteal / Secretory	15–28	High progesterone + moderate E₂ from corpus luteum; inhibin A	Endometrial glands secrete glycogen; negative feedback suppresses GnRH/FSH/LH; if no hCG, corpus luteum regresses → luteolysis

Phases of the menstrual cycle with their hormonal signatures and physiologic events

One of the most commonly tested points on the MCAT involves the fate of the corpus luteum upon fertilization. If the blastocyst implants, the outer trophoblastic layer secretes human chorionic gonadotropin (hCG), which binds LH receptors on the corpus luteum and maintains its progesterone output through the first trimester. This is why pregnancy tests detect hCG in urine—it appears only when a viable implantation has occurred. By the end of the first trimester, the placenta assumes steroidogenic function, producing progesterone, estrogens (especially estriol from fetal DHEA-S), and hPL (human placental lactogen), which modulates maternal metabolism to support fetal growth.

SECTION 6

Worked Example — Clinical Hormonal Reasoning

On the MCAT, reproductive endocrinology questions rarely involve numeric calculations; instead, they test your ability to predict hormonal changes when one component of the HPG axis is altered. The following worked example illustrates the kind of multi-step reasoning required.

Predicting Hormonal Consequences of Ovarian Failure

1
Step 1 — Read the Scenario

A 30-year-old woman presents with amenorrhea (absence of menstruation) for 6 months. Lab work reveals very low estradiol and progesterone levels. You are asked to predict her FSH and LH levels and explain the mechanism.
2
Step 2 — Identify the Defect Location

Low estradiol and progesterone indicate gonadal failure (primary ovarian insufficiency). The ovaries are not producing sex steroids despite expected stimulation.

Defect: end-organ (ovarian) level
3
Step 3 — Apply Feedback Logic

Under normal conditions, estradiol and inhibin exert negative feedback on the hypothalamus and anterior pituitary. When ovarian output is low, this negative feedback is removed. The hypothalamus increases GnRH pulse frequency, and the anterior pituitary gonadotrophs are no longer suppressed.
4
Step 4 — Predict Gonadotropin Levels

Without negative feedback, both FSH and LH will be elevated (hypergonadotropic state). This is the hallmark of primary gonadal failure—elevated gonadotropins with low sex steroids.

FSH: ↑↑ elevated | LH: ↑↑ elevated | E₂: ↓↓ low | Progesterone: ↓↓ low
5
Step 5 — Distinguish from Secondary/Tertiary Causes

If the defect were at the pituitary (secondary hypogonadism), FSH and LH would be low despite low sex steroids—hypogonadotropic hypogonadism. Similarly, hypothalamic dysfunction (e.g., Kallmann syndrome) produces low GnRH, low FSH/LH, and low sex steroids. The distinguishing feature is always whether gonadotropins are high (primary) or low (secondary/tertiary).

Primary failure → ↑ gonadotropins | Secondary/tertiary failure → ↓ gonadotropins

SECTION 7

Male vs. Female Reproductive Endocrinology — Key Comparisons

Feature	Female	Male
Cycling	Cyclical (~28 days); follicular and luteal phases alternate	Tonic (non-cyclical); continuous spermatogenesis
Positive Feedback	Yes — sustained high E₂ triggers LH surge	No — only negative feedback operates
Gametogenesis Output	1 mature oocyte per cycle (typically); finite oocyte pool	~200 million sperm/day; continuous from puberty
Primary Steroid	Estradiol (follicular phase); Progesterone (luteal phase)	Testosterone (also converted to DHT and E₂ peripherally)
FSH Target Cell	Granulosa cells (aromatase expression, follicle growth)	Sertoli cells (ABP, inhibin B, germ cell support)
LH Target Cell	Theca cells (androgen production → substrate for aromatase)	Leydig cells (testosterone synthesis)
Meiotic Arrest	Prophase I (from fetal life); resumes with LH surge → arrests at metaphase II until fertilization	No prolonged arrest; continuous meiosis from spermatogonia

Key differences between female and male reproductive endocrinology

✦

KEY TAKEAWAY

The single feature that distinguishes the female HPG axis from the male axis is the capacity for positive feedback. In the male, the axis functions like a cruise control that slows down when the car exceeds the set speed (negative feedback only). In the female, there is one dramatic moment each month when stepping on the accelerator causes the engine to rev even harder—a brief, explosive positive feedback loop that generates the LH surge and triggers ovulation. All hormonal contraceptives work by preventing this switch to positive feedback, either by providing constant low-level steroids that maintain negative feedback or by suppressing GnRH pulsatility altogether.

SECTION 8

Clinical & Advanced Connections

The MCAT increasingly tests reproductive endocrinology in clinical contexts that require you to extend basic axis physiology to pathologic states and pharmacologic interventions. The table below connects HPG axis concepts to commonly tested disorders and their hormonal signatures.

Condition / Intervention	Mechanism	Hormonal Profile
Polycystic Ovary Syndrome (PCOS)	Elevated LH:FSH ratio; excess ovarian and adrenal androgens; insulin resistance potentiates androgen production	↑ LH, normal/↓ FSH, ↑ androgens, anovulation
Kallmann Syndrome	Failure of GnRH neuron migration from olfactory placode → absent GnRH; associated with anosmia	↓ GnRH, ↓ FSH, ↓ LH, ↓ sex steroids (hypogonadotropic hypogonadism)
Menopause	Depletion of ovarian follicular reserve → loss of estradiol/inhibin production → loss of negative feedback	↑↑ FSH (most reliable marker), ↑ LH, ↓↓ E₂
GnRH Agonist (e.g., Leuprolide)	Continuous GnRH → desensitization/downregulation of pituitary GnRH receptors ("flare then suppression")	Initial ↑ FSH/LH (flare), then ↓↓ FSH/LH → ↓ sex steroids. Used in prostate cancer, endometriosis, IVF protocols.
Combined Oral Contraceptive	Exogenous estrogen + progestin maintain constant negative feedback → suppress GnRH pulsatility and prevent LH surge	↓ FSH, ↓ LH (no surge), no dominant follicle, anovulation
Anabolic Steroid Abuse (Male)	Exogenous testosterone → strong negative feedback on GnRH/LH → testicular atrophy due to loss of intratesticular testosterone	↓ FSH, ↓ LH, ↓ endogenous testosterone, ↓ sperm count, small testes

Clinically relevant conditions and pharmacologic interventions involving the HPG axis

Beyond the HPG axis itself, reproductive endocrinology intersects with several advanced topics that appear on the MCAT. Embryology requires knowledge of sex determination: the SRY gene on the Y chromosome drives differentiation of the bipotential gonad into a testis, which produces Müllerian inhibiting substance (MIS/AMH) to regress the paramesonephric ducts and testosterone to stabilize the mesonephric (Wolffian) ducts. Pregnancy physiology introduces hCG, human placental lactogen (hPL), relaxin, and the role of the fetoplacental unit in estriol synthesis. Lactation involves prolactin (stimulated by suckling, inhibited by dopamine) and oxytocin (milk ejection reflex), both of which link back to hypothalamic-pituitary regulation.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A woman is administered a drug that provides constant, non-pulsatile GnRH stimulation. Predict the effect on her FSH and LH levels after two weeks and explain the underlying mechanism.

Show answer

After an initial transient rise ("flare"), continuous GnRH exposure causes downregulation and desensitization of GnRH receptors on anterior pituitary gonadotrophs. After two weeks, both FSH and LH will be markedly decreased. This occurs because GnRH must be delivered in a pulsatile fashion to maintain receptor sensitivity; continuous exposure leads to receptor internalization and reduced gonadotropin gene transcription. This is the principle behind GnRH agonist therapy (e.g., leuprolide) used to achieve a "medical castration" in conditions such as prostate cancer or endometriosis.

Question 2: BASIC CALCULATION

A patient's blood work shows the following values: FSH = 45 mIU/mL (normal 3–10), LH = 38 mIU/mL (normal 2–12), Estradiol = 15 pg/mL (normal follicular 30–100). Is this primary, secondary, or tertiary hypogonadism? What is the most likely diagnosis in a 52-year-old woman?

Show answer

This is primary hypogonadism (hypergonadotropic hypogonadism). Both gonadotropins are elevated because the ovaries are failing to produce estradiol, removing negative feedback on the hypothalamus and pituitary. In a 52-year-old woman, the most likely diagnosis is menopause (depletion of ovarian follicular reserve). Elevated FSH is the single most reliable laboratory marker of menopause. If this were secondary hypogonadism (pituitary lesion) or tertiary (hypothalamic), both FSH and LH would be low or inappropriately normal despite low estradiol.

Question 3: INTERMEDIATE

During the menstrual cycle, estradiol exerts negative feedback on FSH/LH during most of the follicular phase but switches to positive feedback just before ovulation. What molecular/physiological conditions must be met for this switch, and what would happen to ovulation if a woman received a small, constant dose of exogenous estrogen throughout her cycle?

Show answer

The switch from negative to positive feedback requires that estradiol levels exceed approximately 200 pg/mL and remain at that threshold for approximately 50 hours. This sustained high concentration appears to sensitize pituitary gonadotrophs to GnRH and may increase GnRH receptor expression, amplifying the LH response. If a woman received a constant, small dose of exogenous estrogen, the level would be enough to maintain negative feedback (suppressing FSH and preventing dominant follicle development) but insufficient to cross the threshold for positive feedback. Without a dominant follicle producing escalating estradiol, the LH surge would not occur, and ovulation would be suppressed—this is exactly how combined oral contraceptive pills work.

Question 4: APPLIED

A male bodybuilder has been using exogenous testosterone for 6 months and now wants to conceive. His semen analysis shows severe oligospermia (very low sperm count). Explain the endocrine basis for his infertility and predict his testicular size relative to a normal male.

Show answer

Exogenous testosterone provides strong negative feedback at the hypothalamus and anterior pituitary, suppressing GnRH, FSH, and LH secretion. Without LH stimulation, Leydig cells atrophy and intratesticular testosterone (normally 50–100× higher than serum levels) plummets. Without adequate intratesticular testosterone, Sertoli cells cannot support spermatogenesis. Without FSH, Sertoli cell function is further impaired (reduced ABP, reduced germ cell nourishment). The result is severe oligospermia or azoospermia. His testes would be significantly smaller than normal (testicular atrophy), because approximately 80% of testicular volume is composed of seminiferous tubules, which shrink when spermatogenesis ceases. Recovery typically requires months after cessation of exogenous testosterone, and sometimes exogenous hCG (LH analog) or FSH therapy is needed to restore fertility.

Question 5: CRITICAL THINKING

A researcher discovers a novel mutation in the inhibin gene that renders inhibin B non-functional. Predict the reproductive consequences in both males and females, and explain how the FSH:LH ratio would be affected. Could this mutation cause infertility, enhanced fertility, or both depending on context?

Show answer

Inhibin B selectively suppresses FSH secretion from the anterior pituitary without significantly affecting LH. Loss of functional inhibin B would remove this selective brake, leading to chronically elevated FSH while LH remains normally regulated by sex steroids. In males, elevated FSH would overstimulate Sertoli cells, potentially increasing spermatogenesis initially, but the disrupted paracrine milieu might paradoxically reduce sperm quality. In females, the most significant consequence would be loss of the mechanism that allows only one follicle to achieve dominance. Normally, the rising inhibin B from the dominant follicle helps suppress FSH, causing atresia of competing follicles. Without inhibin, persistently elevated FSH could recruit multiple follicles to maturity, increasing the risk of multiple ovulations and multiple gestations. However, the chronically elevated FSH might also disrupt the precise hormonal timing needed for the positive feedback switch, potentially interfering with the LH surge. Thus, the mutation could paradoxically cause both multiple ovulation (if the cycle proceeds) and anovulatory infertility (if the estradiol profile never achieves the sustained threshold). The FSH:LH ratio would be abnormally elevated, which is a useful diagnostic clue.

SUMMARY

Reproductive System & Hormonal Control — Key Concepts Review

Summary

The hypothalamic-pituitary-gonadal (HPG) axis is a three-tier endocrine cascade in which pulsatile GnRH from the hypothalamus stimulates FSH and LH release from the anterior pituitary, which in turn drive gametogenesis and steroidogenesis in the gonads. Negative feedback by sex steroids (estradiol, progesterone, testosterone) and inhibin (selectively targeting FSH) maintains homeostasis under most conditions. The female cycle is uniquely punctuated by positive feedback: sustained high estradiol triggers the mid-cycle LH surge and ovulation.

The menstrual cycle comprises the follicular/proliferative phase (rising E₂, FSH-driven follicle recruitment) and the luteal/secretory phase (progesterone from the corpus luteum). If fertilization occurs, hCG rescues the corpus luteum. In males, a tonic HPG axis drives continuous spermatogenesis via Leydig cells (LH → testosterone) and Sertoli cells (FSH → ABP, inhibin B). Clinically, distinguishing primary (↑ gonadotropins) from secondary/tertiary (↓ gonadotropins) hypogonadism is the foundational diagnostic framework—and a guaranteed MCAT topic.